Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Colonic Neoplasms | 56 | 2024 | 2541 | 9.180 |
Why?
|
Rectal Neoplasms | 34 | 2025 | 1183 | 7.190 |
Why?
|
Colectomy | 35 | 2024 | 696 | 6.520 |
Why?
|
Colorectal Neoplasms | 36 | 2024 | 6975 | 2.820 |
Why?
|
Neoplasm Staging | 49 | 2023 | 11244 | 2.520 |
Why?
|
Neoadjuvant Therapy | 19 | 2025 | 2907 | 2.130 |
Why?
|
Adenocarcinoma | 31 | 2025 | 6395 | 2.030 |
Why?
|
Laparoscopy | 20 | 2018 | 2041 | 1.660 |
Why?
|
Surgical Wound Infection | 11 | 2017 | 1546 | 1.600 |
Why?
|
Digestive System Surgical Procedures | 12 | 2020 | 583 | 1.470 |
Why?
|
Lymph Nodes | 12 | 2023 | 3474 | 1.440 |
Why?
|
General Surgery | 15 | 2012 | 1720 | 1.400 |
Why?
|
Neoplasm Invasiveness | 25 | 2022 | 3620 | 1.360 |
Why?
|
Carcinoembryonic Antigen | 3 | 2016 | 338 | 1.320 |
Why?
|
Neoplasm Recurrence, Local | 20 | 2023 | 9419 | 1.240 |
Why?
|
Hospitals, Veterans | 13 | 2012 | 395 | 1.240 |
Why?
|
Postoperative Complications | 45 | 2024 | 15833 | 1.150 |
Why?
|
Disease-Free Survival | 24 | 2022 | 6847 | 1.130 |
Why?
|
Lymph Node Excision | 13 | 2024 | 1271 | 1.110 |
Why?
|
Colon, Transverse | 2 | 2018 | 25 | 1.110 |
Why?
|
Anastomotic Leak | 4 | 2024 | 170 | 1.090 |
Why?
|
Workload | 9 | 2012 | 849 | 1.050 |
Why?
|
Retrospective Studies | 111 | 2025 | 81760 | 1.040 |
Why?
|
Survival Rate | 31 | 2024 | 12840 | 0.990 |
Why?
|
Thermodilution | 2 | 2024 | 50 | 0.950 |
Why?
|
Aged | 155 | 2025 | 171502 | 0.940 |
Why?
|
Colonoscopy | 5 | 2019 | 1409 | 0.940 |
Why?
|
Prognosis | 45 | 2025 | 30009 | 0.900 |
Why?
|
Surgical Mesh | 8 | 2009 | 315 | 0.900 |
Why?
|
Middle Aged | 159 | 2025 | 223487 | 0.820 |
Why?
|
Hernia, Ventral | 7 | 2010 | 220 | 0.800 |
Why?
|
Hypoalbuminemia | 1 | 2023 | 90 | 0.800 |
Why?
|
DNA Mismatch Repair | 4 | 2024 | 431 | 0.780 |
Why?
|
Surgical Wound Dehiscence | 4 | 2017 | 216 | 0.780 |
Why?
|
Humans | 259 | 2025 | 768171 | 0.760 |
Why?
|
Neoplasm Metastasis | 10 | 2019 | 4913 | 0.750 |
Why?
|
Rectum | 8 | 2024 | 900 | 0.740 |
Why?
|
Male | 178 | 2025 | 364731 | 0.740 |
Why?
|
Operating Rooms | 6 | 2010 | 790 | 0.740 |
Why?
|
Extracorporeal Membrane Oxygenation | 2 | 2024 | 1483 | 0.730 |
Why?
|
Tumor Microenvironment | 8 | 2024 | 3948 | 0.730 |
Why?
|
Jaundice, Obstructive | 1 | 2020 | 22 | 0.730 |
Why?
|
Carcinoma, Signet Ring Cell | 1 | 2021 | 81 | 0.730 |
Why?
|
Colonic Diseases | 3 | 2012 | 204 | 0.710 |
Why?
|
Hospices | 1 | 2023 | 245 | 0.710 |
Why?
|
Anastomosis, Surgical | 5 | 2024 | 991 | 0.690 |
Why?
|
Female | 176 | 2025 | 397187 | 0.690 |
Why?
|
Colon | 7 | 2024 | 1801 | 0.670 |
Why?
|
United States Department of Veterans Affairs | 5 | 2012 | 937 | 0.670 |
Why?
|
Treatment Outcome | 65 | 2023 | 65379 | 0.670 |
Why?
|
Neoplasm, Residual | 4 | 2021 | 1015 | 0.630 |
Why?
|
Recovery Room | 6 | 2009 | 34 | 0.630 |
Why?
|
Lymphatic Metastasis | 14 | 2020 | 2914 | 0.620 |
Why?
|
Peripheral Nervous System Neoplasms | 1 | 2019 | 133 | 0.620 |
Why?
|
Pancreatic Neoplasms | 15 | 2019 | 5442 | 0.620 |
Why?
|
Aged, 80 and over | 72 | 2024 | 59626 | 0.600 |
Why?
|
Surgical Procedures, Operative | 9 | 2011 | 1933 | 0.600 |
Why?
|
Early Detection of Cancer | 3 | 2018 | 3239 | 0.570 |
Why?
|
Viscera | 1 | 2017 | 138 | 0.570 |
Why?
|
Postanesthesia Nursing | 2 | 2006 | 10 | 0.550 |
Why?
|
Blood Flow Velocity | 1 | 2020 | 1375 | 0.540 |
Why?
|
Hospice Care | 1 | 2023 | 678 | 0.540 |
Why?
|
Follow-Up Studies | 32 | 2020 | 39354 | 0.540 |
Why?
|
Cholecystectomy | 6 | 2020 | 408 | 0.530 |
Why?
|
Ventricular Function, Right | 1 | 2020 | 629 | 0.520 |
Why?
|
Sutures | 3 | 2014 | 283 | 0.520 |
Why?
|
Prone Position | 1 | 2017 | 203 | 0.520 |
Why?
|
Surgical Stapling | 2 | 2014 | 99 | 0.520 |
Why?
|
Liver Neoplasms | 8 | 2020 | 4363 | 0.520 |
Why?
|
Blood Vessels | 2 | 2019 | 1110 | 0.510 |
Why?
|
Metformin | 1 | 2023 | 909 | 0.510 |
Why?
|
Transforming Growth Factor beta | 8 | 2003 | 2004 | 0.510 |
Why?
|
Colon, Descending | 1 | 2015 | 6 | 0.500 |
Why?
|
Neoplasms, Second Primary | 1 | 2023 | 1061 | 0.500 |
Why?
|
Colon, Ascending | 1 | 2015 | 14 | 0.500 |
Why?
|
Age Factors | 10 | 2024 | 18415 | 0.500 |
Why?
|
Laparotomy | 5 | 2012 | 458 | 0.490 |
Why?
|
Cysts | 1 | 2020 | 685 | 0.490 |
Why?
|
Urokinase-Type Plasminogen Activator | 7 | 2010 | 324 | 0.480 |
Why?
|
Incidence | 20 | 2023 | 21538 | 0.480 |
Why?
|
Patient Care Team | 7 | 2011 | 2523 | 0.470 |
Why?
|
Cholecystectomy, Laparoscopic | 6 | 2010 | 236 | 0.470 |
Why?
|
Patient Positioning | 1 | 2017 | 332 | 0.470 |
Why?
|
Models, Animal | 1 | 2020 | 2122 | 0.450 |
Why?
|
Tissue Adhesions | 2 | 2013 | 223 | 0.440 |
Why?
|
Anemia | 1 | 2023 | 1514 | 0.430 |
Why?
|
Academic Medical Centers | 6 | 2010 | 2785 | 0.430 |
Why?
|
Interdisciplinary Communication | 4 | 2011 | 937 | 0.420 |
Why?
|
Length of Stay | 19 | 2018 | 6498 | 0.420 |
Why?
|
Colostomy | 2 | 2017 | 106 | 0.420 |
Why?
|
Emergencies | 4 | 2014 | 1221 | 0.410 |
Why?
|
Healthcare Disparities | 3 | 2015 | 3415 | 0.410 |
Why?
|
Ambulatory Surgical Procedures | 3 | 2017 | 452 | 0.400 |
Why?
|
Adult | 93 | 2025 | 223646 | 0.400 |
Why?
|
Intestinal Mucosa | 5 | 2019 | 3044 | 0.400 |
Why?
|
Obesity | 8 | 2017 | 13091 | 0.400 |
Why?
|
Erythrocyte Transfusion | 1 | 2017 | 575 | 0.400 |
Why?
|
Proportional Hazards Models | 13 | 2022 | 12543 | 0.390 |
Why?
|
Carcinoma | 6 | 2022 | 2332 | 0.380 |
Why?
|
Terminal Care | 1 | 2023 | 1770 | 0.380 |
Why?
|
Survival Analysis | 11 | 2018 | 10099 | 0.380 |
Why?
|
Hospital Costs | 3 | 2008 | 957 | 0.380 |
Why?
|
Rectal Diseases | 2 | 2011 | 142 | 0.380 |
Why?
|
Comorbidity | 13 | 2022 | 10590 | 0.370 |
Why?
|
Risk Factors | 36 | 2024 | 74944 | 0.370 |
Why?
|
Hernia, Abdominal | 2 | 2008 | 58 | 0.370 |
Why?
|
Pancreas | 5 | 2015 | 1699 | 0.370 |
Why?
|
Personnel Staffing and Scheduling | 3 | 2012 | 497 | 0.360 |
Why?
|
Vascular Grafting | 1 | 2012 | 163 | 0.360 |
Why?
|
Polyvinyls | 2 | 2008 | 155 | 0.360 |
Why?
|
Patient Education as Topic | 2 | 2018 | 2337 | 0.360 |
Why?
|
GATA6 Transcription Factor | 1 | 2010 | 54 | 0.360 |
Why?
|
Efficiency, Organizational | 2 | 2006 | 697 | 0.350 |
Why?
|
Multivariate Analysis | 14 | 2017 | 12077 | 0.350 |
Why?
|
Plasminogen | 4 | 1999 | 144 | 0.350 |
Why?
|
Hospital Units | 2 | 2008 | 142 | 0.350 |
Why?
|
Pancreaticoduodenectomy | 2 | 2011 | 516 | 0.340 |
Why?
|
Texas | 7 | 2012 | 410 | 0.340 |
Why?
|
2-Propanol | 1 | 2010 | 28 | 0.340 |
Why?
|
Waist Circumference | 2 | 2010 | 935 | 0.340 |
Why?
|
Povidone-Iodine | 1 | 2010 | 56 | 0.330 |
Why?
|
Microsatellite Instability | 3 | 2021 | 726 | 0.330 |
Why?
|
Forkhead Transcription Factors | 5 | 2022 | 1625 | 0.330 |
Why?
|
Time Management | 2 | 2006 | 53 | 0.330 |
Why?
|
Gallstones | 3 | 2011 | 285 | 0.320 |
Why?
|
Gallbladder Neoplasms | 3 | 2011 | 190 | 0.320 |
Why?
|
Databases, Factual | 6 | 2017 | 8080 | 0.320 |
Why?
|
Chlorhexidine | 1 | 2010 | 159 | 0.310 |
Why?
|
Surgical Stomas | 1 | 2008 | 45 | 0.310 |
Why?
|
Postoperative Period | 5 | 2024 | 1826 | 0.300 |
Why?
|
Transforming Growth Factor beta1 | 4 | 2009 | 642 | 0.300 |
Why?
|
Enterocolitis, Pseudomembranous | 2 | 2008 | 264 | 0.300 |
Why?
|
Intra-Abdominal Fat | 2 | 2010 | 625 | 0.300 |
Why?
|
Hernia, Inguinal | 3 | 2007 | 224 | 0.300 |
Why?
|
Chemotherapy, Adjuvant | 6 | 2021 | 3556 | 0.300 |
Why?
|
Endarterectomy, Carotid | 2 | 2012 | 556 | 0.290 |
Why?
|
Adrenal Gland Diseases | 1 | 2009 | 141 | 0.290 |
Why?
|
Quality of Health Care | 5 | 2013 | 4310 | 0.290 |
Why?
|
Cohort Studies | 26 | 2021 | 41753 | 0.290 |
Why?
|
Inservice Training | 2 | 2011 | 375 | 0.290 |
Why?
|
United States | 28 | 2024 | 73039 | 0.290 |
Why?
|
Early Ambulation | 1 | 2007 | 49 | 0.280 |
Why?
|
Anti-Infective Agents, Local | 1 | 2010 | 247 | 0.280 |
Why?
|
Polypropylenes | 1 | 2007 | 63 | 0.280 |
Why?
|
Immunohistochemistry | 11 | 2024 | 11095 | 0.280 |
Why?
|
Hernia, Umbilical | 2 | 2008 | 102 | 0.280 |
Why?
|
Staphylococcal Skin Infections | 1 | 2007 | 78 | 0.280 |
Why?
|
Abdomen | 4 | 2017 | 1136 | 0.280 |
Why?
|
Body Mass Index | 9 | 2014 | 13053 | 0.280 |
Why?
|
Adrenalectomy | 1 | 2009 | 348 | 0.270 |
Why?
|
Methicillin Resistance | 1 | 2007 | 198 | 0.270 |
Why?
|
Blood-Borne Pathogens | 1 | 2006 | 52 | 0.270 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 2010 | 792 | 0.270 |
Why?
|
Anesthesia, Local | 2 | 2006 | 279 | 0.270 |
Why?
|
Risk Assessment | 18 | 2023 | 24318 | 0.270 |
Why?
|
Surgery Department, Hospital | 1 | 2008 | 170 | 0.270 |
Why?
|
Cause of Death | 5 | 2024 | 3721 | 0.270 |
Why?
|
Needlestick Injuries | 1 | 2006 | 71 | 0.270 |
Why?
|
Logistic Models | 16 | 2015 | 13290 | 0.270 |
Why?
|
GATA4 Transcription Factor | 1 | 2007 | 125 | 0.260 |
Why?
|
Veterans | 6 | 2010 | 2669 | 0.260 |
Why?
|
Cyclonic Storms | 1 | 2008 | 121 | 0.260 |
Why?
|
Patient Admission | 3 | 2014 | 1365 | 0.260 |
Why?
|
Soft Tissue Infections | 1 | 2007 | 168 | 0.250 |
Why?
|
Gallbladder Diseases | 2 | 2010 | 139 | 0.250 |
Why?
|
Combined Modality Therapy | 10 | 2020 | 8542 | 0.250 |
Why?
|
Stromal Cells | 2 | 2021 | 1337 | 0.250 |
Why?
|
Research Support as Topic | 2 | 2010 | 696 | 0.250 |
Why?
|
Smoking | 4 | 2017 | 9092 | 0.250 |
Why?
|
Genes, ras | 2 | 1999 | 663 | 0.240 |
Why?
|
Postoperative Care | 4 | 2018 | 1480 | 0.240 |
Why?
|
Students, Medical | 3 | 2010 | 1964 | 0.240 |
Why?
|
Program Development | 2 | 2010 | 1300 | 0.240 |
Why?
|
Fatty Acid-Binding Proteins | 1 | 2007 | 294 | 0.240 |
Why?
|
Prostaglandin-Endoperoxide Synthases | 3 | 2003 | 319 | 0.240 |
Why?
|
Prospective Studies | 27 | 2024 | 54924 | 0.240 |
Why?
|
Serum Response Factor | 1 | 2004 | 78 | 0.230 |
Why?
|
Attitude of Health Personnel | 4 | 2012 | 3929 | 0.230 |
Why?
|
Carcinoid Tumor | 1 | 2006 | 225 | 0.230 |
Why?
|
Appendiceal Neoplasms | 1 | 2006 | 155 | 0.230 |
Why?
|
Critical Pathways | 2 | 2009 | 476 | 0.220 |
Why?
|
Medical Staff, Hospital | 1 | 2008 | 603 | 0.220 |
Why?
|
Liver Failure | 2 | 2004 | 252 | 0.220 |
Why?
|
beta 2-Microglobulin | 1 | 2024 | 330 | 0.220 |
Why?
|
Diverticulitis, Colonic | 3 | 2024 | 139 | 0.220 |
Why?
|
Hospital Information Systems | 1 | 2006 | 395 | 0.220 |
Why?
|
Patient Discharge | 7 | 2011 | 3479 | 0.220 |
Why?
|
Intraoperative Care | 2 | 2017 | 770 | 0.220 |
Why?
|
Writing | 1 | 2005 | 200 | 0.220 |
Why?
|
Pancreatic Diseases | 2 | 2011 | 353 | 0.210 |
Why?
|
Mass Screening | 3 | 2021 | 5458 | 0.210 |
Why?
|
Kaplan-Meier Estimate | 8 | 2025 | 6525 | 0.210 |
Why?
|
Portasystemic Shunt, Transjugular Intrahepatic | 1 | 2004 | 96 | 0.210 |
Why?
|
Cholecystitis | 1 | 2003 | 181 | 0.210 |
Why?
|
Gastrointestinal Diseases | 2 | 2005 | 1205 | 0.200 |
Why?
|
Propensity Score | 4 | 2018 | 1969 | 0.200 |
Why?
|
Epithelial Cells | 4 | 2009 | 3703 | 0.200 |
Why?
|
Lymphopenia | 1 | 2025 | 300 | 0.200 |
Why?
|
Hand-Assisted Laparoscopy | 2 | 2012 | 15 | 0.200 |
Why?
|
Ascites | 1 | 2004 | 338 | 0.200 |
Why?
|
Faculty, Medical | 1 | 2010 | 1226 | 0.200 |
Why?
|
Health Status Disparities | 1 | 2014 | 1885 | 0.200 |
Why?
|
Gallbladder | 1 | 2003 | 308 | 0.200 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 7 | 2019 | 11878 | 0.200 |
Why?
|
Pancreatitis | 2 | 2008 | 1087 | 0.190 |
Why?
|
Anus Neoplasms | 1 | 2005 | 336 | 0.190 |
Why?
|
Preoperative Care | 6 | 2018 | 2258 | 0.190 |
Why?
|
Cell Culture Techniques | 1 | 2009 | 1667 | 0.190 |
Why?
|
Cardiac Output | 1 | 2024 | 838 | 0.190 |
Why?
|
Hepatectomy | 4 | 2020 | 588 | 0.190 |
Why?
|
Anesthesia | 1 | 2012 | 1596 | 0.190 |
Why?
|
Receptors, Somatostatin | 1 | 2002 | 138 | 0.190 |
Why?
|
Appendectomy | 2 | 2006 | 444 | 0.190 |
Why?
|
Predictive Value of Tests | 14 | 2023 | 15453 | 0.180 |
Why?
|
Isoenzymes | 3 | 2003 | 1688 | 0.180 |
Why?
|
Stomach Neoplasms | 4 | 2021 | 1481 | 0.180 |
Why?
|
Hepatic Duct, Common | 1 | 2020 | 48 | 0.180 |
Why?
|
Immobilization | 1 | 2002 | 229 | 0.180 |
Why?
|
Morbidity | 2 | 2019 | 1755 | 0.180 |
Why?
|
Massachusetts | 5 | 2019 | 8890 | 0.180 |
Why?
|
Promoter Regions, Genetic | 3 | 2017 | 5797 | 0.180 |
Why?
|
Sigmoid Diseases | 2 | 2012 | 60 | 0.180 |
Why?
|
Societies, Medical | 3 | 2017 | 3968 | 0.180 |
Why?
|
Hospitals | 5 | 2012 | 3886 | 0.180 |
Why?
|
Tumor Cells, Cultured | 12 | 2009 | 6124 | 0.180 |
Why?
|
Patient Readmission | 6 | 2017 | 3288 | 0.180 |
Why?
|
Knowledge | 1 | 2002 | 178 | 0.180 |
Why?
|
Popliteal Artery | 1 | 2002 | 313 | 0.170 |
Why?
|
Gangrene | 3 | 2004 | 92 | 0.170 |
Why?
|
Colorectal Surgery | 2 | 2015 | 125 | 0.170 |
Why?
|
Extracellular Matrix | 2 | 2008 | 1738 | 0.160 |
Why?
|
Staphylococcus aureus | 1 | 2007 | 1430 | 0.160 |
Why?
|
Educational Measurement | 2 | 2008 | 1260 | 0.160 |
Why?
|
Peripheral Nerves | 2 | 2016 | 490 | 0.160 |
Why?
|
Interprofessional Relations | 1 | 2005 | 997 | 0.160 |
Why?
|
Anesthesia Recovery Period | 2 | 2012 | 155 | 0.160 |
Why?
|
Anesthetics, Local | 1 | 2006 | 1005 | 0.160 |
Why?
|
Alternative Splicing | 1 | 2004 | 1105 | 0.160 |
Why?
|
Cell Transformation, Neoplastic | 4 | 2004 | 2846 | 0.160 |
Why?
|
Information Dissemination | 1 | 2007 | 1143 | 0.160 |
Why?
|
Tibial Fractures | 1 | 2002 | 276 | 0.160 |
Why?
|
Carcinoma, Papillary | 1 | 2024 | 793 | 0.160 |
Why?
|
Internship and Residency | 7 | 2012 | 5953 | 0.160 |
Why?
|
Demography | 1 | 2023 | 1641 | 0.160 |
Why?
|
Linear Models | 5 | 2012 | 5884 | 0.150 |
Why?
|
Ileostomy | 2 | 2017 | 122 | 0.150 |
Why?
|
Perineum | 2 | 2017 | 212 | 0.150 |
Why?
|
Ileus | 1 | 2018 | 65 | 0.150 |
Why?
|
Liver Abscess | 2 | 2015 | 81 | 0.150 |
Why?
|
HIV | 1 | 2005 | 1597 | 0.150 |
Why?
|
Femoral Fractures | 1 | 2002 | 376 | 0.150 |
Why?
|
Physician-Patient Relations | 2 | 2010 | 3269 | 0.150 |
Why?
|
Adenocarcinoma, Mucinous | 1 | 2022 | 525 | 0.150 |
Why?
|
Analysis of Variance | 5 | 2012 | 6229 | 0.150 |
Why?
|
Liver Cirrhosis | 3 | 2018 | 1960 | 0.150 |
Why?
|
Time Factors | 16 | 2018 | 40220 | 0.150 |
Why?
|
HCT116 Cells | 2 | 2010 | 405 | 0.150 |
Why?
|
Losartan | 1 | 2019 | 262 | 0.140 |
Why?
|
Causality | 1 | 2024 | 1254 | 0.140 |
Why?
|
Quality Assurance, Health Care | 2 | 2009 | 2176 | 0.140 |
Why?
|
Lung | 3 | 2024 | 10101 | 0.140 |
Why?
|
Colonic Polyps | 1 | 2022 | 557 | 0.140 |
Why?
|
Euthanasia, Active | 1 | 1997 | 16 | 0.140 |
Why?
|
Euthanasia, Active, Voluntary | 1 | 1997 | 12 | 0.140 |
Why?
|
Knee Injuries | 1 | 2002 | 495 | 0.140 |
Why?
|
Cardiac Surgical Procedures | 3 | 2011 | 3684 | 0.140 |
Why?
|
Luciferases | 2 | 2010 | 713 | 0.140 |
Why?
|
Heart Valve Prosthesis Implantation | 3 | 2015 | 1566 | 0.140 |
Why?
|
Smad2 Protein | 3 | 2009 | 144 | 0.140 |
Why?
|
Intestinal Neoplasms | 1 | 1999 | 314 | 0.140 |
Why?
|
Pericarditis | 1 | 2018 | 136 | 0.140 |
Why?
|
Neuromuscular Blocking Agents | 1 | 2017 | 132 | 0.130 |
Why?
|
Gene Expression | 2 | 2007 | 7601 | 0.130 |
Why?
|
Euthanasia | 1 | 1997 | 58 | 0.130 |
Why?
|
Inpatients | 2 | 2023 | 2566 | 0.130 |
Why?
|
Immune Tolerance | 1 | 2005 | 2323 | 0.130 |
Why?
|
Intussusception | 1 | 1997 | 116 | 0.130 |
Why?
|
Neuromuscular Blockade | 1 | 2017 | 148 | 0.130 |
Why?
|
Respiration, Artificial | 2 | 2020 | 2726 | 0.130 |
Why?
|
Esophageal Neoplasms | 2 | 2021 | 1668 | 0.130 |
Why?
|
Occupational Exposure | 1 | 2006 | 1807 | 0.130 |
Why?
|
Endotoxins | 2 | 1996 | 519 | 0.130 |
Why?
|
Boston | 4 | 2017 | 9374 | 0.130 |
Why?
|
Appendicitis | 2 | 2000 | 690 | 0.130 |
Why?
|
Keratins | 3 | 2009 | 499 | 0.130 |
Why?
|
Nursing Homes | 1 | 2023 | 1084 | 0.130 |
Why?
|
Streptococcus constellatus | 1 | 2015 | 3 | 0.130 |
Why?
|
Tomography, X-Ray Computed | 10 | 2021 | 20762 | 0.130 |
Why?
|
Bicarbonates | 1 | 2016 | 293 | 0.130 |
Why?
|
Pain, Postoperative | 1 | 2006 | 1765 | 0.130 |
Why?
|
Receptors, Transforming Growth Factor beta | 4 | 2009 | 306 | 0.130 |
Why?
|
Peptide Fragments | 2 | 1998 | 5151 | 0.130 |
Why?
|
Critical Illness | 2 | 2020 | 2755 | 0.130 |
Why?
|
Wounds, Nonpenetrating | 1 | 2002 | 807 | 0.120 |
Why?
|
Hospitals, University | 3 | 2011 | 570 | 0.120 |
Why?
|
Cervical Vertebrae | 1 | 2002 | 979 | 0.120 |
Why?
|
Cholecystitis, Acute | 2 | 2007 | 81 | 0.120 |
Why?
|
Gene Expression Regulation, Neoplastic | 8 | 2021 | 8648 | 0.120 |
Why?
|
Reoperation | 5 | 2018 | 4329 | 0.120 |
Why?
|
Education, Medical, Continuing | 2 | 2010 | 829 | 0.120 |
Why?
|
Azacitidine | 1 | 2017 | 336 | 0.120 |
Why?
|
Sigmoid Neoplasms | 1 | 2015 | 54 | 0.120 |
Why?
|
Inflammatory Bowel Diseases | 2 | 2023 | 2442 | 0.120 |
Why?
|
Recurrence | 7 | 2008 | 8509 | 0.120 |
Why?
|
Carcinoma, Hepatocellular | 3 | 2018 | 2334 | 0.120 |
Why?
|
Repetitive Sequences, Nucleic Acid | 1 | 2017 | 781 | 0.120 |
Why?
|
Muscle, Smooth | 1 | 2019 | 931 | 0.120 |
Why?
|
Referral and Consultation | 1 | 2008 | 3620 | 0.120 |
Why?
|
Lung Neoplasms | 2 | 2019 | 13586 | 0.120 |
Why?
|
Chemoembolization, Therapeutic | 1 | 1995 | 128 | 0.120 |
Why?
|
Torsion Abnormality | 1 | 2015 | 92 | 0.120 |
Why?
|
Colitis | 1 | 2023 | 1242 | 0.120 |
Why?
|
Chi-Square Distribution | 5 | 2012 | 3436 | 0.120 |
Why?
|
Deglutition Disorders | 1 | 2020 | 640 | 0.110 |
Why?
|
Confidence Intervals | 3 | 2012 | 2923 | 0.110 |
Why?
|
Health Status | 1 | 2007 | 4091 | 0.110 |
Why?
|
Hospital Mortality | 6 | 2016 | 5349 | 0.110 |
Why?
|
Early Diagnosis | 1 | 2019 | 1194 | 0.110 |
Why?
|
Multiple Organ Failure | 2 | 1996 | 388 | 0.110 |
Why?
|
Education, Medical, Graduate | 4 | 2012 | 2420 | 0.110 |
Why?
|
Antineoplastic Agents | 4 | 2010 | 13677 | 0.110 |
Why?
|
Camptothecin | 1 | 2017 | 600 | 0.110 |
Why?
|
Smad4 Protein | 2 | 2007 | 193 | 0.110 |
Why?
|
Attitude to Death | 1 | 1997 | 400 | 0.110 |
Why?
|
Intubation, Intratracheal | 1 | 2002 | 1359 | 0.110 |
Why?
|
Informed Consent | 2 | 2010 | 1010 | 0.110 |
Why?
|
Brain Neoplasms | 1 | 2015 | 9118 | 0.110 |
Why?
|
Elastic Tissue | 1 | 2013 | 66 | 0.110 |
Why?
|
Fibrinolysin | 4 | 2003 | 130 | 0.110 |
Why?
|
Pneumonia, Ventilator-Associated | 2 | 2014 | 278 | 0.110 |
Why?
|
Feasibility Studies | 1 | 2024 | 5315 | 0.110 |
Why?
|
Thrombospondin 1 | 3 | 1999 | 257 | 0.110 |
Why?
|
Catheter Ablation | 1 | 2006 | 2780 | 0.100 |
Why?
|
Trans-Activators | 1 | 2002 | 2857 | 0.100 |
Why?
|
Anti-Bacterial Agents | 3 | 2008 | 7477 | 0.100 |
Why?
|
Plasma | 1 | 1996 | 585 | 0.100 |
Why?
|
Calcinosis | 1 | 2001 | 1482 | 0.100 |
Why?
|
Income | 1 | 2021 | 1878 | 0.100 |
Why?
|
Cholelithiasis | 2 | 2011 | 408 | 0.100 |
Why?
|
Short Bowel Syndrome | 1 | 1996 | 352 | 0.100 |
Why?
|
Adenoma | 2 | 2022 | 2159 | 0.100 |
Why?
|
Lymphocytes | 1 | 2020 | 2614 | 0.100 |
Why?
|
Polytetrafluoroethylene | 2 | 2003 | 245 | 0.100 |
Why?
|
Disease Progression | 3 | 2024 | 13668 | 0.100 |
Why?
|
Case-Control Studies | 5 | 2023 | 22290 | 0.100 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2019 | 1767 | 0.100 |
Why?
|
Natural Orifice Endoscopic Surgery | 1 | 2013 | 119 | 0.090 |
Why?
|
Reimbursement, Incentive | 1 | 2017 | 541 | 0.090 |
Why?
|
Perioperative Care | 2 | 2011 | 1043 | 0.090 |
Why?
|
Proctoscopy | 1 | 2011 | 40 | 0.090 |
Why?
|
Thrombospondins | 3 | 2009 | 196 | 0.090 |
Why?
|
Fluorouracil | 4 | 2019 | 1652 | 0.090 |
Why?
|
Embolism, Cholesterol | 1 | 2010 | 32 | 0.090 |
Why?
|
Cell Line, Tumor | 7 | 2021 | 17142 | 0.090 |
Why?
|
Shock, Cardiogenic | 1 | 2016 | 711 | 0.090 |
Why?
|
Quality of Life | 6 | 2024 | 13490 | 0.090 |
Why?
|
Foreign Bodies | 1 | 2015 | 403 | 0.090 |
Why?
|
Colitis, Ulcerative | 1 | 2023 | 1926 | 0.090 |
Why?
|
Hospitals, Private | 1 | 2011 | 67 | 0.090 |
Why?
|
Radiotherapy, Adjuvant | 3 | 2011 | 1791 | 0.090 |
Why?
|
Neutrophils | 2 | 2021 | 3786 | 0.090 |
Why?
|
Learning Curve | 1 | 2012 | 232 | 0.090 |
Why?
|
Streptococcal Infections | 1 | 2015 | 619 | 0.090 |
Why?
|
Proto-Oncogene Proteins B-raf | 4 | 2022 | 2059 | 0.090 |
Why?
|
HT29 Cells | 1 | 2010 | 189 | 0.090 |
Why?
|
Proto-Oncogene Proteins | 3 | 1997 | 4528 | 0.090 |
Why?
|
Models, Statistical | 4 | 2011 | 5107 | 0.090 |
Why?
|
Colon, Sigmoid | 1 | 2011 | 124 | 0.090 |
Why?
|
Swine | 1 | 2020 | 5997 | 0.090 |
Why?
|
Cyclooxygenase 2 | 3 | 2003 | 598 | 0.090 |
Why?
|
Antisepsis | 1 | 2010 | 16 | 0.090 |
Why?
|
RNA Interference | 2 | 2010 | 2832 | 0.090 |
Why?
|
Age of Onset | 1 | 2017 | 3346 | 0.090 |
Why?
|
Abdomen, Acute | 1 | 2010 | 122 | 0.090 |
Why?
|
Aortic Valve Stenosis | 2 | 2015 | 2032 | 0.090 |
Why?
|
Sp1 Transcription Factor | 1 | 2010 | 143 | 0.090 |
Why?
|
Reference Values | 1 | 2017 | 4939 | 0.080 |
Why?
|
Polyps | 1 | 2011 | 200 | 0.080 |
Why?
|
Biomedical Research | 1 | 2005 | 3463 | 0.080 |
Why?
|
Heart Rate | 2 | 2014 | 4214 | 0.080 |
Why?
|
Accreditation | 3 | 2012 | 477 | 0.080 |
Why?
|
Odds Ratio | 4 | 2013 | 9669 | 0.080 |
Why?
|
Seroma | 1 | 2009 | 75 | 0.080 |
Why?
|
Collagen | 3 | 2007 | 2645 | 0.080 |
Why?
|
Research Design | 1 | 2005 | 6209 | 0.080 |
Why?
|
Statistics, Nonparametric | 3 | 2012 | 2862 | 0.080 |
Why?
|
Anesthesia, General | 2 | 2014 | 1189 | 0.080 |
Why?
|
Intensive Care Units | 2 | 2020 | 3800 | 0.080 |
Why?
|
Patient Transfer | 2 | 2006 | 792 | 0.080 |
Why?
|
Suture Techniques | 4 | 2008 | 775 | 0.080 |
Why?
|
Quality Improvement | 2 | 2017 | 3857 | 0.080 |
Why?
|
Spinal Diseases | 1 | 2014 | 561 | 0.080 |
Why?
|
Bacteremia | 2 | 2015 | 985 | 0.080 |
Why?
|
Fecal Incontinence | 1 | 2012 | 246 | 0.080 |
Why?
|
Probability | 5 | 2004 | 2479 | 0.080 |
Why?
|
Biocompatible Materials | 2 | 2007 | 1703 | 0.080 |
Why?
|
Equipment Design | 2 | 2007 | 3522 | 0.080 |
Why?
|
Health Plan Implementation | 1 | 2011 | 338 | 0.080 |
Why?
|
Angiostatins | 2 | 1998 | 64 | 0.080 |
Why?
|
Vimentin | 1 | 2009 | 257 | 0.080 |
Why?
|
Blotting, Western | 2 | 2010 | 5028 | 0.080 |
Why?
|
Cholangiography | 1 | 2008 | 182 | 0.080 |
Why?
|
Digestive System Diseases | 1 | 2009 | 152 | 0.070 |
Why?
|
Warfarin | 2 | 2022 | 1493 | 0.070 |
Why?
|
Transfection | 3 | 2007 | 5756 | 0.070 |
Why?
|
Leukocyte Count | 2 | 2020 | 1609 | 0.070 |
Why?
|
Japan | 3 | 2024 | 1418 | 0.070 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2010 | 858 | 0.070 |
Why?
|
Utilization Review | 2 | 2008 | 381 | 0.070 |
Why?
|
Obesity, Abdominal | 1 | 2011 | 375 | 0.070 |
Why?
|
Suicide, Attempted | 1 | 1997 | 1409 | 0.070 |
Why?
|
Plasminogen Activator Inhibitor 1 | 2 | 1999 | 279 | 0.070 |
Why?
|
Cancer Care Facilities | 1 | 2011 | 427 | 0.070 |
Why?
|
Enoxaparin | 1 | 2010 | 391 | 0.070 |
Why?
|
Cholecystostomy | 1 | 2007 | 54 | 0.070 |
Why?
|
Registries | 1 | 2024 | 8375 | 0.070 |
Why?
|
Positron-Emission Tomography | 3 | 2020 | 6669 | 0.070 |
Why?
|
Data Collection | 1 | 2017 | 3326 | 0.070 |
Why?
|
Cyclins | 2 | 2002 | 606 | 0.070 |
Why?
|
Gastrectomy | 3 | 2009 | 693 | 0.070 |
Why?
|
Pancreatic Fistula | 1 | 2008 | 149 | 0.070 |
Why?
|
Continuity of Patient Care | 2 | 2012 | 1078 | 0.070 |
Why?
|
Tissue Array Analysis | 2 | 2024 | 551 | 0.070 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 2 | 2024 | 1105 | 0.070 |
Why?
|
Cell Division | 4 | 2002 | 4477 | 0.070 |
Why?
|
Serine Proteinase Inhibitors | 2 | 1998 | 174 | 0.070 |
Why?
|
Hemoglobins | 1 | 2013 | 1531 | 0.070 |
Why?
|
Esophagogastric Junction | 1 | 2009 | 351 | 0.070 |
Why?
|
Operating Room Nursing | 1 | 2006 | 25 | 0.070 |
Why?
|
Polymerase Chain Reaction | 3 | 2010 | 6082 | 0.070 |
Why?
|
Rats | 5 | 2004 | 23782 | 0.070 |
Why?
|
Observation | 1 | 2008 | 310 | 0.070 |
Why?
|
Subcutaneous Fat | 1 | 2010 | 404 | 0.070 |
Why?
|
Telemedicine | 1 | 2024 | 3109 | 0.070 |
Why?
|
Bed Occupancy | 1 | 2006 | 38 | 0.070 |
Why?
|
Smad3 Protein | 1 | 2007 | 166 | 0.070 |
Why?
|
Mesoderm | 1 | 2009 | 679 | 0.070 |
Why?
|
Protein Binding | 2 | 2010 | 9343 | 0.070 |
Why?
|
Cost-Benefit Analysis | 4 | 2010 | 5536 | 0.070 |
Why?
|
Leucovorin | 2 | 2019 | 643 | 0.070 |
Why?
|
Recovery of Function | 3 | 2012 | 2981 | 0.070 |
Why?
|
Activin Receptors, Type I | 1 | 2007 | 134 | 0.070 |
Why?
|
Alcoholism | 1 | 2017 | 1980 | 0.070 |
Why?
|
Liver Transplantation | 1 | 2018 | 2401 | 0.070 |
Why?
|
Competency-Based Education | 1 | 2008 | 226 | 0.070 |
Why?
|
Haplorhini | 1 | 2007 | 523 | 0.070 |
Why?
|
Paracrine Communication | 1 | 2008 | 279 | 0.070 |
Why?
|
Clinical Competence | 5 | 2012 | 4858 | 0.060 |
Why?
|
Signal Transduction | 2 | 2007 | 23648 | 0.060 |
Why?
|
Skin, Artificial | 1 | 2006 | 89 | 0.060 |
Why?
|
Abdominal Wall | 1 | 2007 | 166 | 0.060 |
Why?
|
Embolization, Therapeutic | 1 | 1995 | 1401 | 0.060 |
Why?
|
Mutation | 4 | 2022 | 30237 | 0.060 |
Why?
|
Databases as Topic | 1 | 2007 | 472 | 0.060 |
Why?
|
Pancreatectomy | 2 | 2008 | 825 | 0.060 |
Why?
|
Microsurgery | 1 | 2011 | 800 | 0.060 |
Why?
|
Appointments and Schedules | 2 | 2006 | 443 | 0.060 |
Why?
|
Hematoma | 1 | 2010 | 766 | 0.060 |
Why?
|
Psychiatry | 2 | 1997 | 1716 | 0.060 |
Why?
|
Cholangiopancreatography, Endoscopic Retrograde | 1 | 2008 | 520 | 0.060 |
Why?
|
GPI-Linked Proteins | 1 | 2007 | 472 | 0.060 |
Why?
|
Education, Nursing | 1 | 2005 | 83 | 0.060 |
Why?
|
DNA-Binding Proteins | 1 | 2002 | 9617 | 0.060 |
Why?
|
Cardiovascular Diseases | 2 | 2008 | 15662 | 0.060 |
Why?
|
Splanchnic Circulation | 1 | 2005 | 122 | 0.060 |
Why?
|
Dose-Response Relationship, Drug | 4 | 2017 | 10763 | 0.060 |
Why?
|
Technetium Tc 99m Sulfur Colloid | 1 | 2004 | 63 | 0.060 |
Why?
|
Comprehension | 1 | 2010 | 638 | 0.060 |
Why?
|
Deoxycytidine | 2 | 2014 | 887 | 0.060 |
Why?
|
Zinc Fingers | 1 | 2007 | 577 | 0.060 |
Why?
|
Checklist | 1 | 2011 | 840 | 0.060 |
Why?
|
Computer Systems | 1 | 2006 | 469 | 0.060 |
Why?
|
Neurogenesis | 1 | 2011 | 864 | 0.060 |
Why?
|
Medical Errors | 2 | 2003 | 1260 | 0.060 |
Why?
|
Lumbar Vertebrae | 1 | 2014 | 1886 | 0.060 |
Why?
|
Efficiency | 1 | 2008 | 479 | 0.060 |
Why?
|
Spinal Fusion | 1 | 2014 | 1308 | 0.060 |
Why?
|
Cooperative Behavior | 1 | 2011 | 1514 | 0.060 |
Why?
|
Vancomycin | 1 | 2007 | 506 | 0.060 |
Why?
|
Curriculum | 2 | 2010 | 3782 | 0.060 |
Why?
|
History, 21st Century | 1 | 2010 | 1573 | 0.060 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2011 | 957 | 0.060 |
Why?
|
Health Care Costs | 2 | 2010 | 3239 | 0.060 |
Why?
|
Alkaline Phosphatase | 1 | 2007 | 864 | 0.060 |
Why?
|
Neovascularization, Pathologic | 2 | 2008 | 2631 | 0.050 |
Why?
|
Skin | 2 | 2010 | 4505 | 0.050 |
Why?
|
Rupture, Spontaneous | 1 | 2004 | 365 | 0.050 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 2 | 2002 | 379 | 0.050 |
Why?
|
Drug Combinations | 1 | 2010 | 2089 | 0.050 |
Why?
|
Down-Regulation | 2 | 2002 | 2939 | 0.050 |
Why?
|
Sex Characteristics | 1 | 2014 | 2649 | 0.050 |
Why?
|
Intestines | 2 | 2005 | 1909 | 0.050 |
Why?
|
Animals | 9 | 2020 | 169285 | 0.050 |
Why?
|
Membrane Glycoproteins | 3 | 2000 | 3713 | 0.050 |
Why?
|
Infusions, Intra-Arterial | 1 | 2003 | 220 | 0.050 |
Why?
|
Atrial Fibrillation | 1 | 2022 | 5176 | 0.050 |
Why?
|
Magnetic Resonance Imaging | 3 | 2020 | 36741 | 0.050 |
Why?
|
Patient Care Management | 1 | 2006 | 303 | 0.050 |
Why?
|
Genes, Reporter | 1 | 2007 | 1524 | 0.050 |
Why?
|
Smad6 Protein | 1 | 2002 | 14 | 0.050 |
Why?
|
Matched-Pair Analysis | 1 | 2023 | 285 | 0.050 |
Why?
|
Teaching | 1 | 2010 | 1171 | 0.050 |
Why?
|
Point Mutation | 2 | 1999 | 1596 | 0.050 |
Why?
|
DNA Methylation | 1 | 2017 | 4428 | 0.050 |
Why?
|
Heart Ventricles | 1 | 2015 | 3841 | 0.050 |
Why?
|
History, 20th Century | 1 | 2010 | 2766 | 0.050 |
Why?
|
Radiology, Interventional | 1 | 2006 | 483 | 0.050 |
Why?
|
Binding Sites | 1 | 2010 | 6019 | 0.050 |
Why?
|
Cell Communication | 1 | 2009 | 1660 | 0.050 |
Why?
|
Cells, Cultured | 3 | 2003 | 19025 | 0.050 |
Why?
|
Hospitals, Teaching | 1 | 2006 | 1157 | 0.050 |
Why?
|
Cell Line, Transformed | 1 | 2003 | 866 | 0.050 |
Why?
|
Fibroblasts | 2 | 2009 | 4178 | 0.050 |
Why?
|
Ultrasonography | 5 | 2015 | 6004 | 0.050 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2005 | 794 | 0.050 |
Why?
|
Acute Disease | 3 | 2018 | 7243 | 0.050 |
Why?
|
Tumor Suppressor Protein p53 | 3 | 2014 | 2956 | 0.050 |
Why?
|
MutS Homolog 2 Protein | 1 | 2022 | 200 | 0.050 |
Why?
|
Actins | 1 | 2009 | 2064 | 0.050 |
Why?
|
Cell Movement | 2 | 2010 | 5213 | 0.050 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2007 | 1243 | 0.050 |
Why?
|
Insurance, Health | 1 | 2014 | 2517 | 0.050 |
Why?
|
Autocrine Communication | 1 | 2002 | 168 | 0.050 |
Why?
|
Risk Adjustment | 1 | 2005 | 599 | 0.050 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2002 | 317 | 0.050 |
Why?
|
Cyclooxygenase Inhibitors | 1 | 2003 | 361 | 0.050 |
Why?
|
Conscious Sedation | 1 | 2006 | 534 | 0.050 |
Why?
|
Biopsy, Needle | 2 | 2004 | 1623 | 0.050 |
Why?
|
Cryosurgery | 1 | 2006 | 479 | 0.050 |
Why?
|
Cyclooxygenase 2 Inhibitors | 1 | 2003 | 319 | 0.050 |
Why?
|
Microbial Sensitivity Tests | 1 | 2007 | 1967 | 0.050 |
Why?
|
Fractals | 1 | 2021 | 127 | 0.050 |
Why?
|
Sentinel Lymph Node Biopsy | 2 | 2004 | 737 | 0.050 |
Why?
|
Emergency Treatment | 1 | 2004 | 497 | 0.040 |
Why?
|
Cell Compartmentation | 1 | 2021 | 383 | 0.040 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2009 | 3806 | 0.040 |
Why?
|
Cross Infection | 1 | 2010 | 1425 | 0.040 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2008 | 1657 | 0.040 |
Why?
|
Socioeconomic Factors | 2 | 2012 | 7852 | 0.040 |
Why?
|
Fibrinolytic Agents | 1 | 2010 | 2080 | 0.040 |
Why?
|
Receptors, Cell Surface | 3 | 1999 | 2819 | 0.040 |
Why?
|
Carcinoma, Ductal, Breast | 2 | 1999 | 1099 | 0.040 |
Why?
|
Patient Selection | 2 | 2010 | 4260 | 0.040 |
Why?
|
Catheterization, Central Venous | 1 | 2005 | 537 | 0.040 |
Why?
|
Hematologic Tests | 1 | 2021 | 239 | 0.040 |
Why?
|
Adolescent | 12 | 2018 | 89169 | 0.040 |
Why?
|
Aortic Valve | 1 | 2010 | 1970 | 0.040 |
Why?
|
Protein Structure, Tertiary | 1 | 2007 | 3772 | 0.040 |
Why?
|
Safety Management | 1 | 2005 | 765 | 0.040 |
Why?
|
Pain Measurement | 2 | 2010 | 3583 | 0.040 |
Why?
|
Cardiopulmonary Bypass | 1 | 2005 | 1097 | 0.040 |
Why?
|
Spinal Cord Injuries | 1 | 2007 | 928 | 0.040 |
Why?
|
APACHE | 2 | 2010 | 268 | 0.040 |
Why?
|
Switzerland | 1 | 2020 | 323 | 0.040 |
Why?
|
Stroke | 1 | 2022 | 9755 | 0.040 |
Why?
|
Sex Distribution | 1 | 2004 | 2278 | 0.040 |
Why?
|
CD4 Lymphocyte Count | 1 | 2005 | 2596 | 0.040 |
Why?
|
Young Adult | 10 | 2018 | 60066 | 0.040 |
Why?
|
Cefonicid | 1 | 1998 | 7 | 0.040 |
Why?
|
Acute-Phase Proteins | 1 | 2000 | 252 | 0.040 |
Why?
|
Gene Expression Regulation | 1 | 1997 | 11930 | 0.040 |
Why?
|
Cell Adhesion | 2 | 2003 | 3097 | 0.040 |
Why?
|
HIV Infections | 1 | 2005 | 17569 | 0.040 |
Why?
|
Drug Resistance | 2 | 2002 | 1599 | 0.040 |
Why?
|
Patient Care | 1 | 2004 | 629 | 0.040 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2002 | 710 | 0.040 |
Why?
|
Mucins | 1 | 2022 | 570 | 0.040 |
Why?
|
Antigens, Neoplasm | 1 | 2007 | 1996 | 0.040 |
Why?
|
Age Distribution | 1 | 2004 | 2873 | 0.040 |
Why?
|
Diabetes Mellitus | 2 | 2010 | 5891 | 0.040 |
Why?
|
Transgenes | 1 | 2002 | 1016 | 0.040 |
Why?
|
Guidelines as Topic | 1 | 2005 | 1397 | 0.040 |
Why?
|
Endosonography | 1 | 2002 | 626 | 0.040 |
Why?
|
HIV Antibodies | 1 | 2005 | 1341 | 0.040 |
Why?
|
Depressive Disorder | 1 | 2011 | 3721 | 0.040 |
Why?
|
Sensitivity and Specificity | 6 | 2014 | 14729 | 0.040 |
Why?
|
Culture Media, Serum-Free | 1 | 1998 | 148 | 0.040 |
Why?
|
Phagocytes | 1 | 2000 | 294 | 0.040 |
Why?
|
Melanoma | 1 | 1997 | 5706 | 0.040 |
Why?
|
Quality Indicators, Health Care | 1 | 2008 | 1805 | 0.040 |
Why?
|
Fatty Liver | 1 | 2004 | 810 | 0.040 |
Why?
|
Aprotinin | 1 | 1998 | 94 | 0.040 |
Why?
|
Aortic Aneurysm, Abdominal | 1 | 2008 | 1250 | 0.040 |
Why?
|
Plasminogen Activators | 1 | 1998 | 199 | 0.040 |
Why?
|
Axilla | 2 | 1998 | 623 | 0.040 |
Why?
|
Regression Analysis | 1 | 2007 | 6340 | 0.040 |
Why?
|
Polymorphism, Restriction Fragment Length | 1 | 1999 | 766 | 0.040 |
Why?
|
Radionuclide Imaging | 2 | 2004 | 2000 | 0.040 |
Why?
|
Tracheostomy | 1 | 2002 | 430 | 0.040 |
Why?
|
RNA, Small Interfering | 1 | 2007 | 3428 | 0.040 |
Why?
|
Patient Compliance | 1 | 1988 | 2697 | 0.040 |
Why?
|
Skin Neoplasms | 1 | 1997 | 5863 | 0.040 |
Why?
|
Cephalosporins | 1 | 1998 | 200 | 0.040 |
Why?
|
Platelet Count | 1 | 2020 | 787 | 0.040 |
Why?
|
RNA, Viral | 1 | 2005 | 2874 | 0.030 |
Why?
|
Chemokines | 1 | 2021 | 963 | 0.030 |
Why?
|
Patient Satisfaction | 2 | 2012 | 3490 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2002 | 998 | 0.030 |
Why?
|
Angiography | 1 | 2002 | 1597 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-raf | 1 | 1997 | 205 | 0.030 |
Why?
|
Pharyngitis | 1 | 2018 | 222 | 0.030 |
Why?
|
Myeloid Cells | 1 | 2021 | 839 | 0.030 |
Why?
|
Ischemia | 1 | 2005 | 1900 | 0.030 |
Why?
|
Vascular Surgical Procedures | 1 | 2005 | 1508 | 0.030 |
Why?
|
Accidents, Traffic | 1 | 2002 | 818 | 0.030 |
Why?
|
Bone Morphogenetic Proteins | 1 | 2021 | 846 | 0.030 |
Why?
|
Psychiatric Department, Hospital | 1 | 1996 | 133 | 0.030 |
Why?
|
Treatment Failure | 1 | 2002 | 2661 | 0.030 |
Why?
|
Pelvis | 1 | 2020 | 736 | 0.030 |
Why?
|
Communication | 1 | 2010 | 3905 | 0.030 |
Why?
|
Appendix | 1 | 1997 | 110 | 0.030 |
Why?
|
Organoplatinum Compounds | 1 | 2017 | 408 | 0.030 |
Why?
|
Breast Neoplasms | 5 | 1999 | 21207 | 0.030 |
Why?
|
Salmon | 1 | 2015 | 34 | 0.030 |
Why?
|
Social Values | 1 | 1997 | 224 | 0.030 |
Why?
|
Myocardial Infarction | 1 | 2016 | 11519 | 0.030 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1997 | 492 | 0.030 |
Why?
|
Sulfones | 1 | 1998 | 448 | 0.030 |
Why?
|
Up-Regulation | 3 | 1999 | 4149 | 0.030 |
Why?
|
Immunity | 1 | 2021 | 1003 | 0.030 |
Why?
|
Cultural Characteristics | 1 | 1997 | 250 | 0.030 |
Why?
|
Anesthesiology | 1 | 2005 | 1137 | 0.030 |
Why?
|
Ligands | 1 | 2022 | 3284 | 0.030 |
Why?
|
Child | 7 | 2011 | 80917 | 0.030 |
Why?
|
Leadership | 1 | 2004 | 1397 | 0.030 |
Why?
|
Models, Theoretical | 1 | 2007 | 3573 | 0.030 |
Why?
|
Gastrointestinal Transit | 1 | 1996 | 101 | 0.030 |
Why?
|
Diarrhea | 1 | 2002 | 1320 | 0.030 |
Why?
|
Blood Proteins | 1 | 2000 | 1191 | 0.030 |
Why?
|
Pneumoperitoneum, Artificial | 1 | 1994 | 42 | 0.030 |
Why?
|
Intestinal Absorption | 1 | 1996 | 401 | 0.030 |
Why?
|
Terminally Ill | 1 | 1997 | 240 | 0.030 |
Why?
|
Heart Diseases | 1 | 2007 | 2819 | 0.030 |
Why?
|
Genes, p53 | 1 | 1997 | 714 | 0.030 |
Why?
|
Vietnam | 1 | 2015 | 415 | 0.030 |
Why?
|
Cell Survival | 1 | 2004 | 5789 | 0.030 |
Why?
|
Hepatic Artery | 1 | 1995 | 232 | 0.030 |
Why?
|
Thiazoles | 1 | 2022 | 1542 | 0.030 |
Why?
|
Receptors, Urokinase Plasminogen Activator | 3 | 1999 | 75 | 0.030 |
Why?
|
Severity of Illness Index | 5 | 2020 | 15949 | 0.030 |
Why?
|
Adrenal Cortex Neoplasms | 1 | 1995 | 161 | 0.030 |
Why?
|
Radiopharmaceuticals | 1 | 2004 | 2735 | 0.030 |
Why?
|
Hospitalization | 4 | 2009 | 10840 | 0.030 |
Why?
|
Entropy | 1 | 2014 | 211 | 0.030 |
Why?
|
Accidental Falls | 1 | 2002 | 1080 | 0.030 |
Why?
|
Palliative Care | 2 | 2006 | 3643 | 0.030 |
Why?
|
Biopsy | 1 | 2005 | 6792 | 0.030 |
Why?
|
Antibiotic Prophylaxis | 1 | 1998 | 640 | 0.030 |
Why?
|
Adenomatous Polyposis Coli Protein | 1 | 2014 | 182 | 0.030 |
Why?
|
Sampling Studies | 2 | 2004 | 615 | 0.030 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2017 | 12252 | 0.030 |
Why?
|
Liver Function Tests | 2 | 2004 | 526 | 0.030 |
Why?
|
Electrocardiography | 2 | 2018 | 6412 | 0.030 |
Why?
|
Antibodies | 2 | 1998 | 2421 | 0.030 |
Why?
|
Portal Vein | 1 | 1995 | 435 | 0.030 |
Why?
|
Bariatric Medicine | 1 | 2012 | 12 | 0.030 |
Why?
|
Phenotype | 2 | 2009 | 16726 | 0.030 |
Why?
|
Pyrazoles | 1 | 2003 | 2028 | 0.030 |
Why?
|
Genetic Markers | 1 | 1999 | 2603 | 0.030 |
Why?
|
Nuclear Proteins | 2 | 1997 | 5804 | 0.030 |
Why?
|
Cholecystolithiasis | 1 | 2011 | 7 | 0.020 |
Why?
|
Health Status Indicators | 2 | 2010 | 969 | 0.020 |
Why?
|
Tumor Suppressor Proteins | 1 | 2002 | 2810 | 0.020 |
Why?
|
Reproducibility of Results | 1 | 2010 | 20225 | 0.020 |
Why?
|
Monocytes | 1 | 2021 | 2605 | 0.020 |
Why?
|
Sepsis | 1 | 2005 | 2608 | 0.020 |
Why?
|
Internationality | 1 | 1997 | 1008 | 0.020 |
Why?
|
Enzyme Activation | 1 | 1997 | 3590 | 0.020 |
Why?
|
Cell Line | 2 | 2003 | 15602 | 0.020 |
Why?
|
Operating Room Technicians | 1 | 2010 | 15 | 0.020 |
Why?
|
Body Weight | 1 | 2022 | 4627 | 0.020 |
Why?
|
Parenteral Nutrition | 1 | 1996 | 663 | 0.020 |
Why?
|
Israel | 2 | 2004 | 726 | 0.020 |
Why?
|
Delivery of Health Care | 1 | 2009 | 5367 | 0.020 |
Why?
|
Pilot Projects | 1 | 2024 | 8741 | 0.020 |
Why?
|
Cell Cycle Proteins | 1 | 2002 | 3445 | 0.020 |
Why?
|
Multiple Trauma | 1 | 1993 | 369 | 0.020 |
Why?
|
Apoptosis | 2 | 2004 | 9527 | 0.020 |
Why?
|
Geriatric Assessment | 2 | 2011 | 1422 | 0.020 |
Why?
|
GTP Phosphohydrolases | 1 | 2014 | 525 | 0.020 |
Why?
|
Practice Guidelines as Topic | 1 | 2008 | 7454 | 0.020 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2019 | 2055 | 0.020 |
Why?
|
Myocarditis | 1 | 2018 | 802 | 0.020 |
Why?
|
Membrane Proteins | 2 | 2014 | 7876 | 0.020 |
Why?
|
Anal Canal | 1 | 2013 | 376 | 0.020 |
Why?
|
DNA, Neoplasm | 1 | 1995 | 1744 | 0.020 |
Why?
|
Radiotherapy Dosage | 1 | 2017 | 2916 | 0.020 |
Why?
|
Hypertension | 1 | 2010 | 8616 | 0.020 |
Why?
|
Pyridines | 1 | 2022 | 2894 | 0.020 |
Why?
|
RNA, Messenger | 2 | 2002 | 12801 | 0.020 |
Why?
|
ROC Curve | 2 | 2010 | 3628 | 0.020 |
Why?
|
Intestine, Small | 1 | 1996 | 1217 | 0.020 |
Why?
|
Abdominal Fat | 1 | 2011 | 221 | 0.020 |
Why?
|
Staining and Labeling | 1 | 2013 | 1080 | 0.020 |
Why?
|
Systems Theory | 1 | 2009 | 57 | 0.020 |
Why?
|
Risk | 1 | 2001 | 9613 | 0.020 |
Why?
|
Cell Dedifferentiation | 1 | 2009 | 125 | 0.020 |
Why?
|
Sequence Analysis, RNA | 1 | 2017 | 2040 | 0.020 |
Why?
|
Anesthetics | 1 | 2014 | 525 | 0.020 |
Why?
|
Autoantibodies | 1 | 1997 | 2121 | 0.020 |
Why?
|
Abdominal Pain | 1 | 2015 | 1070 | 0.020 |
Why?
|
Personnel Selection | 1 | 2011 | 201 | 0.020 |
Why?
|
Rupture | 1 | 2010 | 444 | 0.020 |
Why?
|
Sex Factors | 3 | 2012 | 10632 | 0.020 |
Why?
|
Endothelial Cells | 1 | 2021 | 3589 | 0.020 |
Why?
|
Medical Indigency | 1 | 1988 | 63 | 0.020 |
Why?
|
International Normalized Ratio | 1 | 2010 | 382 | 0.020 |
Why?
|
Active Transport, Cell Nucleus | 1 | 2009 | 432 | 0.020 |
Why?
|
Work Schedule Tolerance | 1 | 2012 | 553 | 0.020 |
Why?
|
Diagnosis, Differential | 2 | 2015 | 13013 | 0.020 |
Why?
|
Dissection | 1 | 2009 | 299 | 0.020 |
Why?
|
Hospitals, General | 1 | 2012 | 809 | 0.020 |
Why?
|
Fever | 1 | 2015 | 1614 | 0.020 |
Why?
|
Unnecessary Procedures | 1 | 2011 | 412 | 0.020 |
Why?
|
Psychotherapy | 1 | 1997 | 1654 | 0.020 |
Why?
|
Specialization | 1 | 2012 | 779 | 0.020 |
Why?
|
Transcription, Genetic | 1 | 2021 | 7609 | 0.020 |
Why?
|
Triage | 1 | 2014 | 997 | 0.020 |
Why?
|
Blood Loss, Surgical | 1 | 2011 | 642 | 0.020 |
Why?
|
Genotype | 1 | 2022 | 13045 | 0.020 |
Why?
|
Quinazolines | 1 | 2014 | 1373 | 0.020 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2009 | 615 | 0.020 |
Why?
|
Hernia, Femoral | 1 | 2006 | 18 | 0.020 |
Why?
|
Carrier Proteins | 1 | 2000 | 4939 | 0.020 |
Why?
|
Organizational Policy | 1 | 2009 | 435 | 0.020 |
Why?
|
Social Support | 1 | 1997 | 2193 | 0.020 |
Why?
|
Endoscopy, Digestive System | 1 | 2009 | 358 | 0.020 |
Why?
|
Genetic Testing | 1 | 2019 | 3591 | 0.020 |
Why?
|
Sarcoma | 1 | 1997 | 1806 | 0.020 |
Why?
|
Cell Adhesion Molecules | 3 | 1997 | 1613 | 0.020 |
Why?
|
Anticoagulants | 1 | 2022 | 4850 | 0.020 |
Why?
|
Area Under Curve | 1 | 2010 | 1643 | 0.020 |
Why?
|
Models, Organizational | 1 | 2009 | 548 | 0.020 |
Why?
|
Fluid Therapy | 1 | 2009 | 587 | 0.020 |
Why?
|
New York | 1 | 1988 | 882 | 0.020 |
Why?
|
Esophagectomy | 1 | 2009 | 481 | 0.020 |
Why?
|
Angioplasty | 1 | 2008 | 356 | 0.020 |
Why?
|
Coculture Techniques | 1 | 2009 | 1344 | 0.020 |
Why?
|
Catheters, Indwelling | 1 | 2007 | 436 | 0.020 |
Why?
|
Models, Educational | 1 | 2008 | 375 | 0.020 |
Why?
|
Health Care Surveys | 1 | 2012 | 2434 | 0.020 |
Why?
|
Surgical Flaps | 1 | 2014 | 1682 | 0.020 |
Why?
|
Health Facility Size | 1 | 2005 | 59 | 0.020 |
Why?
|
Cadherins | 1 | 2009 | 905 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 2 | 1997 | 362 | 0.010 |
Why?
|
Neoplasm Proteins | 1 | 1997 | 3604 | 0.010 |
Why?
|
Liver Cirrhosis, Alcoholic | 1 | 2004 | 64 | 0.010 |
Why?
|
Bone and Bones | 1 | 2015 | 2590 | 0.010 |
Why?
|
Silicones | 1 | 2005 | 228 | 0.010 |
Why?
|
Rosaniline Dyes | 1 | 2004 | 50 | 0.010 |
Why?
|
Waiting Lists | 1 | 2009 | 779 | 0.010 |
Why?
|
Minocycline | 1 | 2005 | 170 | 0.010 |
Why?
|
Hemodynamics | 1 | 1994 | 4194 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2021 | 10266 | 0.010 |
Why?
|
Ilium | 1 | 2004 | 155 | 0.010 |
Why?
|
Epigenesis, Genetic | 1 | 2017 | 3833 | 0.010 |
Why?
|
Serum Albumin | 1 | 2006 | 677 | 0.010 |
Why?
|
Rifampin | 1 | 2005 | 352 | 0.010 |
Why?
|
Lumbosacral Region | 1 | 2004 | 294 | 0.010 |
Why?
|
Gene Silencing | 1 | 2009 | 1505 | 0.010 |
Why?
|
Radiotherapy | 1 | 2009 | 1502 | 0.010 |
Why?
|
Educational Status | 1 | 2010 | 2515 | 0.010 |
Why?
|
Digestive System Neoplasms | 1 | 2002 | 82 | 0.010 |
Why?
|
Mitomycin | 1 | 2003 | 261 | 0.010 |
Why?
|
Prostatectomy | 1 | 2010 | 1786 | 0.010 |
Why?
|
Catheterization | 1 | 2007 | 1430 | 0.010 |
Why?
|
Venous Thrombosis | 1 | 2011 | 1321 | 0.010 |
Why?
|
SEER Program | 1 | 2007 | 1444 | 0.010 |
Why?
|
Ventricular Function, Left | 1 | 2015 | 3941 | 0.010 |
Why?
|
Electronic Health Records | 1 | 2019 | 4887 | 0.010 |
Why?
|
Gastroesophageal Reflux | 1 | 2009 | 836 | 0.010 |
Why?
|
Inflammation | 1 | 2021 | 10873 | 0.010 |
Why?
|
Thrombosis | 1 | 1995 | 2957 | 0.010 |
Why?
|
Population Surveillance | 1 | 2011 | 2596 | 0.010 |
Why?
|
Immunoenzyme Techniques | 1 | 2004 | 1703 | 0.010 |
Why?
|
Coronary Artery Bypass | 1 | 2010 | 2191 | 0.010 |
Why?
|
Titanium | 1 | 2003 | 495 | 0.010 |
Why?
|
Intraoperative Complications | 1 | 2006 | 1171 | 0.010 |
Why?
|
Arthroplasty, Replacement, Hip | 1 | 2010 | 1417 | 0.010 |
Why?
|
Antisense Elements (Genetics) | 1 | 1999 | 37 | 0.010 |
Why?
|
Liver | 1 | 2015 | 7578 | 0.010 |
Why?
|
Bone Transplantation | 1 | 2004 | 925 | 0.010 |
Why?
|
Safety | 1 | 2003 | 1159 | 0.010 |
Why?
|
Enzyme Induction | 1 | 1999 | 455 | 0.010 |
Why?
|
Pulmonary Embolism | 1 | 2011 | 2599 | 0.010 |
Why?
|
Enzyme Precursors | 1 | 1998 | 166 | 0.010 |
Why?
|
Antibodies, Neoplasm | 1 | 1999 | 283 | 0.010 |
Why?
|
Antimicrobial Cationic Peptides | 1 | 2000 | 352 | 0.010 |
Why?
|
Critical Care | 1 | 2010 | 2715 | 0.010 |
Why?
|
Blood Vessel Prosthesis Implantation | 1 | 2008 | 1459 | 0.010 |
Why?
|
Geriatrics | 1 | 2002 | 394 | 0.010 |
Why?
|
Diagnostic Imaging | 1 | 2011 | 3533 | 0.010 |
Why?
|
Polymorphism, Single-Stranded Conformational | 1 | 1997 | 325 | 0.010 |
Why?
|
Mental Disorders | 1 | 1996 | 6873 | 0.010 |
Why?
|
Mitotane | 1 | 1995 | 20 | 0.010 |
Why?
|
Computer Simulation | 1 | 2009 | 6283 | 0.010 |
Why?
|
Emergency Medical Services | 1 | 2006 | 1947 | 0.010 |
Why?
|
Cell Count | 1 | 1999 | 1832 | 0.010 |
Why?
|
Evaluation Studies as Topic | 1 | 1996 | 1627 | 0.010 |
Why?
|
Antibody Specificity | 1 | 1996 | 1065 | 0.010 |
Why?
|
Mortality | 1 | 2005 | 2911 | 0.010 |
Why?
|
Activities of Daily Living | 1 | 2003 | 2430 | 0.010 |
Why?
|
Immunoblotting | 1 | 1997 | 1648 | 0.010 |
Why?
|
Infusions, Intravenous | 1 | 1998 | 2230 | 0.010 |
Why?
|
Lymphoma | 1 | 2002 | 1898 | 0.010 |
Why?
|
Nitroglycerin | 1 | 1994 | 332 | 0.010 |
Why?
|
Leukocytes, Mononuclear | 1 | 2000 | 1854 | 0.010 |
Why?
|
Statistics as Topic | 1 | 1999 | 2357 | 0.010 |
Why?
|
Neoplasm Transplantation | 1 | 1996 | 2014 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 1999 | 3814 | 0.010 |
Why?
|
Aneuploidy | 1 | 1995 | 573 | 0.010 |
Why?
|
Exons | 1 | 1997 | 2394 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2011 | 26379 | 0.010 |
Why?
|
Coronary Artery Disease | 1 | 2010 | 6568 | 0.010 |
Why?
|
Rabbits | 1 | 1996 | 4773 | 0.010 |
Why?
|
Mice, Nude | 1 | 1996 | 3623 | 0.010 |
Why?
|
Peritoneal Neoplasms | 1 | 1996 | 714 | 0.010 |
Why?
|
Injury Severity Score | 1 | 1993 | 1049 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2005 | 8052 | 0.010 |
Why?
|
Kinetics | 1 | 1996 | 6330 | 0.000 |
Why?
|
Algorithms | 1 | 2009 | 14164 | 0.000 |
Why?
|
Head and Neck Neoplasms | 1 | 2002 | 2931 | 0.000 |
Why?
|
Prevalence | 1 | 2004 | 15869 | 0.000 |
Why?
|
Monitoring, Physiologic | 1 | 1994 | 1798 | 0.000 |
Why?
|
Sequence Analysis, DNA | 1 | 1997 | 4786 | 0.000 |
Why?
|
Double-Blind Method | 1 | 1998 | 12466 | 0.000 |
Why?
|
Disease Models, Animal | 1 | 1996 | 18349 | 0.000 |
Why?
|
Mice | 1 | 1996 | 82049 | 0.000 |
Why?
|